Clindamycin HCl Capsule — Class II drug recall D-0411-2025
Ongoing recall by RemedyRePack Inc., reported 2025-05-14, distributed in FL, PA, VA. CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
| Recall number | D-0411-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRePack Inc., Indiana, PA, United States |
| Recall initiated | 2025-04-22 |
| Classified | 2025-05-06 |
| Reported by FDA | 2025-05-14 |
| Distributed | FL, PA, VA |
| Reason classes | cgmp |
| NDC | 70518-3772-02 |
| Lot numbers | B3688703-032625, B3698036-033125 |
| Expiration dates | 2026-07-31 |
Product
Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02
Reason for recall
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0411-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.